News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Medical Device Industry Veteran Angela Horacek Joins AlloSource as VP of Operations



4/13/2011 1:17:17 PM

CENTENNIAL, Colo., April 13, 2011 /PRNewswire/ -- AlloSource, one of the nation's largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures and the world's largest processor of live cellular bone growth substitutes, today announced the hire of Angela Horacek as the Vice President, Operations.

In this role Horacek, a seasoned medical device and operations expert, will oversee the broad range of AlloSource operations including donor receiving and medical records clearance, as well as tissue processing and release.

"It is with great pleasure that we welcome Angela to the AlloSource Executive Leadership Team, where her industry experience, strategic operational thought process and exceptional rapport with people will be great assets for our organization," said Thomas Cycyota, president and CEO of AlloSource. "We are dedicated to advancing the possibilities of tissue transplantation to better serve patients and honor the brave gift of life from donors and their families, and Angela's expertise will help us support this goal."

Horacek comes to AlloSource from nSpire Health, a leading developer and manufacturer of respiratory care products, where she was most recently the Global Vice President of Operations and Quality. In this role, Horacek was responsible for manufacturing, supply chain, logistics, facilities and quality and regulatory services for three facilities around the world. Prior to her role at nSpire Health, she held positions of increasing responsibility in operations for several medical device and pharmaceutical organizations.

Horacek holds a bachelor's degree in chemical engineering, a MBA from the University of Louisiana in Lafayette, and a master's degree in Conflict Resolution from the University of Denver.

AlloSource, a nonprofit organization and one of the nation's premier tissue networks, has provided a range of tissue allografts including bone, skin and joint grafts to its local communities around the country for more than fifteen years. The Company has recently expanded into osteobiologics offerings, which help to stimulate natural bone formation, and has pioneered the use of mesenchymal stem cells derived from donor adipose tissue for orthopedic applications. AlloSource has facilitated approximately 100,000 live stem cell transplants worldwide, becoming the world's largest provider of stem cell tissue for surgeries.

About AlloSource

AlloSource delivers powerful possibilities to the medical community, patients and donor families. AlloSource is a non-profit company that offers more than 200 precise bone, skin, soft-tissue and custom-machined allografts for use in a host of life-saving and life-enhancing medical procedures. As the world's leader in fresh cartilage tissue used for joint repair and skin allografts to heal severe burns, AlloSource has become one of the largest and most respected tissue networks in the country. It is also the world's largest processor of live cellular bone growth substitutes. AlloSource delivers unparalleled expertise and responsive customer service to its growing network of surgeons, partners and the country's most reputable organ procurement organizations. AlloSource is accredited by the American Association of Tissue Banks (AATB) and operates in Centennial, CO. For more information, visit www.allosource.org.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Thomas Cycyota

http://www.profnetconnect.com/thomas_cycyota

SOURCE AlloSource


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES